SPLENOMEGALY
Clinical trials for SPLENOMEGALY explained in plain language.
Never miss a new study
Get alerted when new SPLENOMEGALY trials appear
Sign up with your email to follow new studies for SPLENOMEGALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to shrink spleen and boost transplant success in bone marrow cancer
Disease control Recruiting nowThis study tests whether giving high doses of ruxolitinib and busulfan before a stem cell transplant can reduce spleen size and improve transplant outcomes in people with myelofibrosis. About 30 adults aged 18 to 75 with an enlarged spleen and a matched donor will take part. The …
Matched conditions: SPLENOMEGALY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New hope for rare blood disorder: ruxolitinib trial targets eosinophils
Disease control Recruiting nowThis study tests the drug ruxolitinib in 10 people with hypereosinophilic syndrome or related disorders, where high levels of eosinophils (a type of white blood cell) cause organ damage. The goal is to see if ruxolitinib can lower eosinophil counts and improve symptoms. Participa…
Matched conditions: SPLENOMEGALY
Phase: PHASE2 • Sponsor: William Shomali • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC